A randomised interventional trial of ω-3-polyunsaturated fatty acids on endothelial function and disease activity in systemic lupus erythematosus

Annals of the Rheumatic Diseases

Volumn 67, Issue 6, 2008, Pages 841-848

  Wright, Stephen ^a,b   O'Prey, F M ^a   McHenry, M T ^a,b   Leahey, W J ^a   Devine, A B ^a   Duffy, E M ^a,c   Johnston, D G ^a   Finch, M B ^a,b   Bell, A L ^a,b   McVeigh, G E ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b MUSGRAVE PARK HOSPITAL   (United Kingdom)

^c UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

8 ISOPROSTANE; ACETYLSALICYLIC ACID; CHLOROQUINE; DOCOSAHEXAENOIC ACID; FATTY ACID; HORMONE; HYDROXYCHLOROQUINE; ICOSAPENTAENOIC ACID; MEMBRANE LIPID; NONSTEROID ANTIINFLAMMATORY AGENT; OMEGA 3 FATTY ACID; PLACEBO; PREDNISOLONE;

ADULT; ARTERY BLOOD FLOW; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD VESSEL FUNCTION; BRACHIAL ARTERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE ACTIVITY; DOUBLE BLIND PROCEDURE; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG WITHDRAWAL; FEMALE; FUNCTIONAL ASSESSMENT; HEART PROTECTION; HORMONE SUBSTITUTION; HUMAN; INTERVENTION STUDY; LIPID ANALYSIS; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PARALLEL DESIGN; PRIORITY JOURNAL; PROTEIN CONTENT; RANDOMIZED CONTROLLED TRIAL; SYSTEMIC LUPUS ERYTHEMATOSUS; THERAPY EFFECT; THROMBOCYTE; THROMBOCYTE MEMBRANE; VASCULAR ENDOTHELIUM; VASODILATATION;

ADULT; BIOLOGICAL MARKERS; BRACHIAL ARTERY; CELL MEMBRANE; DIETARY SUPPLEMENTS; DINOPROST; DOCOSAHEXAENOIC ACIDS; DOUBLE-BLIND METHOD; ENDOTHELIUM, VASCULAR; FATTY ACIDS, OMEGA-3; FATTY ACIDS, UNSATURATED; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; NITROGLYCERIN; REGIONAL BLOOD FLOW; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, PULSED; VASODILATION; VASODILATOR AGENTS;

EID: 45149085801     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2007.077156     Document Type: Article

References (52)

1. Urowitz MB, Bookman ASM, Koehler BE, Gordon DA, Smythe HA, Ogryzlo MA. The bimodal mortality pattern of systemic lupus erythematosus. Am J Med 1976;60:221-5.
2. Bruce IN, Gladman DD, Urowitz MB. Premature atherosclerosis in systemic lupus erythematosus. Rheum Dis Clin North Am 2000;26:257-78.
3. Manzi S, Meilahn EN, Rairie JE. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham study. Am J Epidemiol 1997;145:408- 15.
4. Petri M, Perez-Gutthann S, Spence D, Hochberg MC. Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am J Med 1992;93:513-19.
5. Roman MJ, Shanker BA, Davis A, Lockshin MD, Sammaritano L, Simantov R, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003;349:2399-406.
6. Bruce IN, Gladman DD, Ibanez D, Urowitz MB. Single photon emission computed tomography dual isotope myocardial perfusion imaging in women with systemic lupus erythematosus. II. Predictive factors for perfusion abnormalities. J Rheumatol 2003;30:288-91.
7. Asanuma Y, Oeser A, Shintani AK, Turner E, Olsen N, Fazio S, et al. Premature coronary-artery atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003;349:2407-15.
8. Wright SA, O'Prey FM, Rea DJ, Plumb RD, Gamble AJ, Leahey WJ, et al. Microcirculatory haemodynamics and endothelial dysfunction in systemic lupus erythematosus. Arterioscler Thromb 2006;26:2281-7.
9. Wright SA, O'Prey FM, Rea DJ, McHenry M, Johnston DG, McGivern RC, et al. Subclinical impairment of arterial mechanic in systemic lupus erythematosus identified by arterial waveform analysis. Rheumatol Int 2007;27:961-8.
10. Bang HO, Dyerberg, J, Hjoorne, N. The composition of food consumed by Greenland Eskimos. Acta Med Scand 1976;200:69-73.
11. Bucher HC, Hengstler P, Schindler C, Meier G. N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med 2002;112:298-304.
12. McVeigh GE, Brennan GM, Cohn JN, Finkelstein SM, Hayes RJ, Johnston GD. Fish oil improves arterial compliance in non-insulin-dependent diabetes mellitus. Arteriosclerosis Thromb 1994;14:1425-9.
13. McVeigh GE, Brennan GM, Johnston GD, McDermott BJ, McGrath LT, Henry WR, et al. Dietary fish oil augments nitric oxide production or release in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1993;36:33-8.
14. Goodfellow J, Bellamy MF, Ramsey MW, Jones CJ, Lewis MJ. Dietary supplementation with marine omega-3 fatty acids improve systemic large artery endothelial function in subjects with hypercholesterolemia. J Am Coll Cardiol 2000;35:265-70.
15. Fleischhauer FJ, Yan WD, Fischell TA. Fish oil improves endothelium-dependent coronary vasodilation in heart transplant recipients. J Am Coll Cardiol 1993;21:982-9.
16. Okumura T, Fujioka Y, Morimoto S, Tsuboi S, Masai M, Tsujino T, et al. Eicosapentaenoic acid improves endothelial function in hypertriglyceridemic subjects despite increased lipid oxidizability. Am J Med Sci 2002;324:247-53.
17. Morgan DR, Dixon LJ, Hanratty CG, El Sherbeeny N, Hamilton PB, McGrath LT, et al. Effects of dietary omega-3 fatty acid supplementation on endothelium-dependent vasodilation in patients with chronic heart failure. Am J Cardiol 2006;97:547-51.
18. Jolly CA, Muthukumar A, Reddy Avula CP, Fernandes G. Maintenance of NF-kappaB activation in T-lymphocytes and a naive T-cell population in autoimmune-prone (NZB/NZW)F(1) mice by feeding a food-restricted diet enriched with n-3 fatty acids. Cell Immunol 2001;213:122-33.
19. Reddy Avula CP, Lawrence RA, Zaman K, Fernandes G. Inhibition of intracellular peroxides and apoptosis of lymphocytes in lupus-prone B/W mice by dietary n-6 and n-3 lipids with calorie restriction. J Clin Immunol 2002;22:206-19.
20. Muthukumar A, Zaman K, Lawrence R, Barnes JL, Fernandes G. Food restriction and fish oil suppress atherogenic risk factors in lupus-prone (NZB x NZW) F1 mice. J Clin Immunol 2003;23:23-33.
21. Muthukumar A, Sun D, Zaman K, Barnes JL, Haile D, Fernandes G. Age associated alterations in costimulatory and adhesion molecule expression in lupus-prone mice are attenuated by food restriction with n-6 and n-3 fatty acids. J Clin Immunol 2004;24:471-80.
22. Duffy EM, Meenagh GK, McMillan SA, Strain JJ, Hannigan BM, Bell AL. The clinical effect of dietary supplementation with omega-3 fish oils and/or copper in systemic lupus erythematosus. J Rheumatol 2004;31:1551- 6.
23. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725-.
24. Liang MH, Socher SA, Larsen MG, Schur PH. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989;32:1107-18.
25. Hay EM, Bacon PA, Gordon C, Isenberg DA, Maddison P, Snaith ML, et al. The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. Q.J Med 1993;86:447-58.
26. Gladman DD, Urowitz MB, Goldsmith CH, Fortin P, Ginzler E, Gordon C. The reliability of the systemic lupus international collaborating clinics/American College of Rheumatology damage index in patients with systemic lupus erythematosus. Arthritis Rheum 1997;40:809-13.
27. Dixon LJ, Morgan DR, Hughes SM, McGrath LT, El Sherbeeny NA, Plumb RD, et al. Functional conseguences of endothelial nitric oxide synthase uncoupling in congestive cardiac failure. Circulation 2003;107:1725-8.
28. McGrath LT, Dixon L, Morgan DR, McVeigh GE. Production of 8-epi prostaglandin F(2alpha) in human platelets during administration of organic nitrates. J Am Coll Cardiol 2002;40:820-5.
29. Mitchell GF, Parise H, Vita JA, Larson MG, Warner E, Kearney JF, et al. Local shear stress and brachial artery flow-mediated dilatation. Hypertension 2004;44:134-9.
30. Clark WF, Parbtani A, Huff MW, Reid B, Holub BJ, Falardeau P. Omega-3 fatty acid dietary supplementation in systemic lupus erythematosus. Kidney Int 1989;36:653-60.
31. Walton AJ, Snaith ML, Locniskar M, Cumberland AG, Morrow WJ, Isenberg DA. Dietary fish oil and the severity of symptoms in patients with systemic lupus erythematosus. Ann Rheum Dis 1991;50:463-6.
32. Nakamura N, Kumasaka R, Osawa H, Yamabe H, Shirato K, Fujita T, et al. Effects of eicosapentaenoic acids on oxidative stress and plasma fatty acid composition in patients with lupus nephritis. In Vivo 2005;19:879-82.
33. Mohan IK, Das UN. Oxidant stress, anti-oxidants and essential fatty acids in systemic lupus erythematosus. Prostaglandins Leukot Essent Fatty Acids 1997;56:193-8.
34. Lewis RA, Austen, KF, Soberman, RJ. Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. N Engl J Med 1990;323:645-55.
35. Yaqoob P, Pala HS, Cortina-Borja M, Newsholme EA, Calder PC. Encapsulated fish oil enriched in alpha-tocopherol alters plasma phospholipid and mononuclear cell fatty acid compositions but not mononuclear cell functions. Eur J Clin Invest 2000;30:260-74.
36. Endres S, Ghorbani R, Kelley VE, Georgilis K, Lonnemann G, van der Meer JW, et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989;320:265-71.
37. Vanning K, Schmidt EB, Svaneborg N, Moller JM, Lervang HH, Grunnet N, et al. The effect of n-3 fatty acids on neutrophil chemiluminescence. Scand J Clin Lab Invest 1995;55:47-52.
38. Fisher M, Levine PH, Weiner BH, Johnson MH, Doyle EM, Ellis PA, et al. Dietary n-3 fatty acid supplementation reduces superoxide production and chemiluminescence in a monocyte-enriched preparation of leukocytes. Am J Clin Nutr 1990;51:804-8.
39. Caughey GE, Mantzioris E, Gibson RA, Cleland LG, James MJ. The effect on human tumor necrosis factor alpha and interleukin 1 beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. Am J Clin Nutr 1996;63:116-22.
40. Miles EA, Thies F, Wallace FA, Powell JR, Hurst TL, Newsholme EA, et al. Influence of age and dietary fish oil on plasma soluble adhesion molecule concentrations. Clin Sci (Lond) 2001;100:91-100.
41. Thies F, Miles EA, Nebe-von-Caron G, Powell JR, Hurst TL, Newsholme EA, et al. Influence of dietary supplementation with long-chain n-3 or n-6 polyunsaturated fatty acids on blood inflammatory cell populations and functions and on plasma soluble adhesion molecules in healthy adults. Lipids 2001;36:1183-93.
42. Alarcon de la Lastra C, Barranco MD, Motilva V, Herrerias JM. Mediterranean diet and health: biological importance of olive oil. Curr Pharm Des 2001;7:933-50.
43. Bondia-Pons I, Schroder H, Covas MI, Castellote AI, Kaikkonen J, Poulsen HE, et al. Moderate consumption of olive oil by healthy European men reduces systolic blood pressure in non-Mediterranean participants. J Nutr 2007;137:84-7.
44. Visioli F, Caruso D, Galli C, Viappiani S, Galli G, Sala A. Olive oils rich in natural catecholic phenols decrease isoprostane excretion in humans. Biochem Biophys Res Commun 2000;278:797-9.
45. Westberg G, Tarkowski A. Effect of MaxEPA in patients with SLE. A double-blind, crossover study. Scand J Rheumatol 1990;19:137-43.
46. Esdaile JM, Abrahamowicz M, Joseph L, Mackenzie T, Li Y, Danoff D. Laboratory tests as predictors of disease exacerbations in systemic lupus erythematosus. Why some test fail. Arthritis Rheum 1996;39:370-8.
47. Goirand F, Ovide-Bordeaux S, Renaud JF, Grynberg A, Lacour B. Effect of dietary docosahexaenoic acid on the endothelium-dependent vasorelaxation in diabetic rats. Clin Exp Pharmacol Physiol 2005;32:184-90.
48. Okuda Y, Kawashima K, Sawada T, Tsurumaru K, Asano M, Suzuki S, et al. Eicosapentaenoic acid enhances nitric oxide production by cultured human endothelial cells. Biochem Biophys Res Commun 1997;232:487- 91.
49. Mori TA, Watts GF, Burke V, Hilme E, Puddey IB, Beilin LJ. Differential effects of eicosapenaenoic acid and docosahexaenoic acid on vascular reactivity of the forearm microcirculation in hyperlipidemic men. Circulation 2000;102:1264-9.
50. Feron O, Belhassen L, Kobzik L, Smith TW, Kelly RA, Michel T. Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells. J Biol Chem 1996;271:22810-14.
51. Michel JB, Feron O, Sase K, Prabhakar P, Michel T. Caveolin versus calmodulin. Counterbalancing allosteric modulators of endothelial nitric oxide synthase. J Biol Chem 1997;272:25907-12.
52. Omura M, Kobayashi S, Mizukami Y, Mogami K, Todoroki-Ikeda N, Miyake T, et al. Eicosapentaenoic acid (EPA) induces Ca(2+)-independent activation and translocation of endothelial nitric oxide synthase and endothelium-dependent vasorelaxation. FEBS Lett 2001;487:361-6.